Sign in Sign up for free

Last updated: 27 December 2023 at 6:15pm EST

Cary Sucoff Net Worth




The estimated Net Worth of Cary Sucoff is at least $64.8 Thousand dollars as of 20 December 2023. Mr. Sucoff owns over 3,333 units of ContraFect Corp stock worth over $2,318 and over the last 10 years he sold CFRX stock worth over $0. In addition, he makes $62,479 as Independent Director at ContraFect Corp.

Mr. Sucoff CFRX stock SEC Form 4 insiders trading

Cary has made over 10 trades of the ContraFect Corp stock since 2016, according to the Form 4 filled with the SEC. Most recently he exercised 3,333 units of CFRX stock worth $773 on 20 December 2023.

The largest trade he's ever made was exercising 250,000 units of ContraFect Corp stock on 9 February 2016 worth over $192,500. On average, Cary trades about 20,639 units every 120 days since 2015. As of 20 December 2023 he still owns at least 10,000 units of ContraFect Corp stock.

You can see the complete history of Mr. Sucoff stock trades at the bottom of the page.





Cary Sucoff biography

Cary W. Sucoff J.D. serves as Independent Director of the Company. Mr. Sucoff has more than 30 years of securities industry experience encompassing supervisory, banking and sales responsibilities. He has participated in the financing of more than 100 public and private biotech companies. Since 2011, Mr. Sucoff has owned and operated Equity Source Partners LLC, an advisory and consulting firm. In addition to ContraFect, Mr. Sucoff currently serves on the board of directors of Legacy Education Alliance and First Wave Technologies, Inc. In addition, Mr. Sucoff currently serves as a consultant to Sapience Therapeutics and Galimedix Pharmaceuticals Inc. Mr. Sucoff is the past President of New England Law/Boston, has been a member of the Board of Trustees for over 25 years and is the current Chairman of the Endowment Committee. Mr. Sucoff received a B.A. from SUNY Binghamton in 1974 and a J.D. from New England School of Law in 1977, where he was managing editor of the Law Review and graduated magna cum laude. He has been a member of the Bar of the State of New York since 1978.

What is the salary of Cary Sucoff?

As the Independent Director of ContraFect Corp, the total compensation of Cary Sucoff at ContraFect Corp is $62,479. There are 12 executives at ContraFect Corp getting paid more, with Roger Pomerantz having the highest compensation of $1,875,610.



How old is Cary Sucoff?

Cary Sucoff is 68, he's been the Independent Director of ContraFect Corp since 2010. There are 2 older and 14 younger executives at ContraFect Corp. The oldest executive at ContraFect Corp is Sol Barer, 72, who is the Lead Independent Director.

What's Cary Sucoff's mailing address?

Cary's mailing address filed with the SEC is C/O IMAC HOLDINGS, INC., 1605 WESTGATE CIRCLE, BRENTWOOD, TN, 37027.

Insiders trading at ContraFect Corp

Over the last 10 years, insiders at ContraFect Corp have traded over $2,523,392 worth of ContraFect Corp stock and bought 525,578 units worth $426,359 . The most active insiders traders include Sol J Barer, Roger Pomerantz, and Industrial Co., Ltd Fosun. On average, ContraFect Corp executives and independent directors trade stock every 70 days with the average trade being worth of $16,159. The most recent stock trade was executed by Michael Messinger on 13 December 2019, trading 5,000 units of CFRX stock currently worth $1,850.



What does ContraFect Corp do?

we are a biotechnology company focused on protein and antibody therapeutic products for life-threatening infectious diseases, particularly those treated in hospital-based settings. due to drug-resistant and newly-emerging pathogens, infections in the hospital are already the fourth leading cause of death in the united states, following heart disease, cancer and stroke. we address multi-drug resistant infections using our therapeutic products from our lysin and monoclonal antibody platforms to target the conserved regions of either bacteria or viruses. our strategy is to use our first in class therapies to achieve a leadership position in the treatment of life-threatening infectious diseases, including drug-resistant pathogens. we plan to pursue commercialization of therapeutic products through discovery, acquisition and development of protein and antibody products. our novel lysins are enzymes that are produced in the life cycle stage of bacteriophage, a virus that infects and kills ba



What does ContraFect Corp's logo look like?

ContraFect Corp logo

Complete history of Mr. Sucoff stock trades at ContraFect Corp and IMAC Inc

Date
#
Company
 Insider
Trans.
Transaction
 Shares Price per share Total value Shares after Source
20 Dec 2023 IMAC IMAC Holdings Inc Cary Sucoff
Director
 Option 3,333 $0.99 $3,300
20 Dec 2023
10,000 ↗
1 Jan 2022 IMAC IMAC Holdings Inc Cary Sucoff
Director
 Option 50,000 $1.14 $57,000
1 Jan 2022
100,000 ↗
1 Nov 2021 IMAC IMAC Holdings Inc Cary Sucoff
Director
 Option 12,500 $1.40 $17,500
1 Nov 2021
50,000 ↗
1 Aug 2021 IMAC IMAC Holdings Inc Cary Sucoff
Director
 Option 12,500 $1.59 $19,875
1 Aug 2021
37,500 ↗
30 Apr 2021 IMAC IMAC Holdings Inc Cary Sucoff
Director
 Option 12,500 $1.80 $22,500
30 Apr 2021
25,000 ↗
31 Jan 2021 IMAC IMAC Holdings Inc Cary Sucoff
Director
 Option 12,500 $1.68 $21,000
31 Jan 2021
12,500 ↗
13 Dec 2019 CFRX ContraFect Corp Cary Sucoff
Director
 Buy 50,000 $0.39 $19,500
13 Dec 2019
62,000 ↗
25 Jul 2017 CFRX ContraFect Corp Cary Sucoff
Director
 Buy 12,000 $1.24 $14,880
25 Jul 2017
12,000 ↗


ContraFect Corp executives and stock owners

ContraFect Corp executives and other stock owners filed with the SEC include: